GB0717636D0 - Shock-stopper 2 - Google Patents

Shock-stopper 2

Info

Publication number
GB0717636D0
GB0717636D0 GBGB0717636.5A GB0717636A GB0717636D0 GB 0717636 D0 GB0717636 D0 GB 0717636D0 GB 0717636 A GB0717636 A GB 0717636A GB 0717636 D0 GB0717636 D0 GB 0717636D0
Authority
GB
United Kingdom
Prior art keywords
stopper
shock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0717636.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB0717636.5A priority Critical patent/GB0717636D0/en
Publication of GB0717636D0 publication Critical patent/GB0717636D0/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/715Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons
    • G01N2333/7158Assays involving receptors, cell surface antigens or cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/32Cardiovascular disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
GBGB0717636.5A 2007-09-11 2007-09-11 Shock-stopper 2 Ceased GB0717636D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB0717636.5A GB0717636D0 (en) 2007-09-11 2007-09-11 Shock-stopper 2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0717636.5A GB0717636D0 (en) 2007-09-11 2007-09-11 Shock-stopper 2

Publications (1)

Publication Number Publication Date
GB0717636D0 true GB0717636D0 (en) 2007-10-17

Family

ID=38640552

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0717636.5A Ceased GB0717636D0 (en) 2007-09-11 2007-09-11 Shock-stopper 2

Country Status (1)

Country Link
GB (1) GB0717636D0 (en)

Similar Documents

Publication Publication Date Title
GB0717636D0 (en) Shock-stopper 2
AU316643S (en) Bed - SE 2
GB0717640D0 (en) Hydrodechlorification 2
GB0717641D0 (en) Hydrodechlorification 3
GB0723129D0 (en) Plug-shield 3
GB0723178D0 (en) 3 EasyHead
GB0700177D0 (en) Mintop 1
GB0711402D0 (en) Combination 501
GB0711078D0 (en) Combination 500
GB0721823D0 (en) Concept 39
GB0721824D0 (en) Concept 40
GB0706442D0 (en) Concept 11
GB0724810D0 (en) Concept 43
GB0710752D0 (en) Concept 3
GB0724811D0 (en) Concept 44
GB0701275D0 (en) Concept 26
GB0701274D0 (en) Concept 40
GB0721826D0 (en) Concept 42
GB0700161D0 (en) Concept 40
GB0700160D0 (en) Concept 39
GB0710759D0 (en) Concept 19
GB0721822D0 (en) Concept 38
GB0721820D0 (en) Concept 37
GB0721818D0 (en) Concept 36
GB0710747D0 (en) Concept 4

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)